Clicky

Achieve Life Sciences Inc(SP4P) News

Date Title
Jul 3 ACHV: Achieve’s Busy Day
Jun 30 Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
Jun 27 Sector Update: Health Care Stocks Retreat Late Afternoon
Jun 27 Top Midday Decliners
Jun 27 Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
Jun 26 Achieve Life Sciences Announces Proposed Underwritten Public Offering
Jun 26 Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades
Jun 26 Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
Mar 12 ACHV: 2Q:25 NDA Submission
Mar 12 Q4 2024 Achieve Life Sciences Inc Earnings Call
Mar 12 Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
Mar 11 Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program
Feb 18 Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)